ArticleThe American journal of pathology2012

Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.

Jachinta E Rooney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.